107 related articles for article (PubMed ID: 1473151)
1. The cytoplasmic carboxy-terminal amino acid specifies cleavage of membrane TGF alpha into soluble growth factor.
Bosenberg MW; Pandiella A; Massagué J
Cell; 1992 Dec; 71(7):1157-65. PubMed ID: 1473151
[TBL] [Abstract][Full Text] [Related]
2. The cytoplasmic carboxy-terminal amino acid determines the subcellular localization of proTGF-(alpha) and membrane type matrix metalloprotease (MT1-MMP).
Ureña JM; Merlos-Suárez A; Baselga J; Arribas J
J Cell Sci; 1999 Mar; 112 ( Pt 6)():773-84. PubMed ID: 10036228
[TBL] [Abstract][Full Text] [Related]
3. Activated release of membrane-anchored TGF-alpha in the absence of cytosol.
Bosenberg MW; Pandiella A; Massagué J
J Cell Biol; 1993 Jul; 122(1):95-101. PubMed ID: 8314849
[TBL] [Abstract][Full Text] [Related]
4. Phorbol ester-induced activation of a membrane-bound candidate pro-transforming growth factor-alpha processing enzyme.
Harano T; Mizuno K
J Biol Chem; 1994 Aug; 269(32):20305-11. PubMed ID: 8051125
[TBL] [Abstract][Full Text] [Related]
5. Multiple metalloproteinases process protransforming growth factor-alpha (proTGF-alpha).
Hinkle CL; Mohan MJ; Lin P; Yeung N; Rasmussen F; Milla ME; Moss ML
Biochemistry; 2003 Feb; 42(7):2127-36. PubMed ID: 12590602
[TBL] [Abstract][Full Text] [Related]
6. A role for a PDZ protein in the early secretory pathway for the targeting of proTGF-alpha to the cell surface.
Fernández-Larrea J; Merlos-Suárez A; Ureña JM; Baselga J; Arribas J
Mol Cell; 1999 Apr; 3(4):423-33. PubMed ID: 10230395
[TBL] [Abstract][Full Text] [Related]
7. The carboxyl-terminal valine residues of proTGF alpha are required for its efficient maturation and intracellular routing.
Briley GP; Hissong MA; Chiu ML; Lee DC
Mol Biol Cell; 1997 Aug; 8(8):1619-31. PubMed ID: 9285829
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor alpha: expression, regulation and biological action of its integral membrane precursor.
Luetteke NC; Lee DC
Semin Cancer Biol; 1990 Aug; 1(4):265-75. PubMed ID: 2103501
[TBL] [Abstract][Full Text] [Related]
9. Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors.
Arribas J; Coodly L; Vollmer P; Kishimoto TK; Rose-John S; Massagué J
J Biol Chem; 1996 May; 271(19):11376-82. PubMed ID: 8626692
[TBL] [Abstract][Full Text] [Related]
10. Human keratinocytes and tumor-derived cell lines express alternatively spliced forms of transforming growth factor-alpha mRNA, encoding precursors lacking carboxyl-terminal valine residues.
Xu X; Liao J; Creek KE; Pirisi L
Oncogene; 1999 Sep; 18(40):5554-62. PubMed ID: 10523832
[TBL] [Abstract][Full Text] [Related]
11. Role of the juxtamembrane domains of the transforming growth factor-alpha precursor and the beta-amyloid precursor protein in regulated ectodomain shedding.
Arribas J; López-Casillas F; Massagué J
J Biol Chem; 1997 Jul; 272(27):17160-5. PubMed ID: 9202036
[TBL] [Abstract][Full Text] [Related]
12. Association of the transmembrane TGF-alpha precursor with a protein kinase complex.
Shum L; Reeves SA; Kuo AC; Fromer ES; Derynck R
J Cell Biol; 1994 May; 125(4):903-16. PubMed ID: 8188754
[TBL] [Abstract][Full Text] [Related]
13. Cleavage of membrane-anchored growth factors involves distinct protease activities regulated through common mechanisms.
Pandiella A; Bosenberg MW; Huang EJ; Besmer P; Massagué J
J Biol Chem; 1992 Nov; 267(33):24028-33. PubMed ID: 1385433
[TBL] [Abstract][Full Text] [Related]
14. Integral membrane glycoprotein properties of the prohormone pro-transforming growth factor-alpha.
Teixidó J; Gilmore R; Lee DC; Massagué J
Nature; 1987 Apr 30-May 6; 326(6116):883-5. PubMed ID: 3574460
[TBL] [Abstract][Full Text] [Related]
15. Cleavage of the membrane precursor for transforming growth factor alpha is a regulated process.
Pandiella A; Massagué J
Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1726-30. PubMed ID: 2000380
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-alpha and beta-amyloid precursor protein share a secretory mechanism.
Arribas J; Massagué J
J Cell Biol; 1995 Feb; 128(3):433-41. PubMed ID: 7844156
[TBL] [Abstract][Full Text] [Related]
17. Structural properties of a soluble bioactive precursor for transforming growth factor-alpha.
Teixidó J; Massagué J
J Biol Chem; 1988 Mar; 263(8):3924-9. PubMed ID: 2964444
[TBL] [Abstract][Full Text] [Related]
18. Distribution of transforming growth factor alpha precursors in the mouse uterus during the periimplantation period and after steroid hormone treatments.
Paria BC; Das SK; Huet-Hudson YM; Dey SK
Biol Reprod; 1994 Mar; 50(3):481-91. PubMed ID: 8167219
[TBL] [Abstract][Full Text] [Related]
19. Transmembrane transforming growth factor-alpha tethers to the PDZ domain-containing, Golgi membrane-associated protein p59/GRASP55.
Kuo A; Zhong C; Lane WS; Derynck R
EMBO J; 2000 Dec; 19(23):6427-39. PubMed ID: 11101516
[TBL] [Abstract][Full Text] [Related]
20. Unique carboxyl-terminal sequences of wild type and alternatively spliced variant forms of transforming growth factor-alpha precursors mediate specific interactions with ErbB4 and ErbB2.
Xu X; Kelleher KF; Liao J; Creek KE; Pirisi L
Oncogene; 2000 Jun; 19(28):3172-81. PubMed ID: 10918572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
